« Back
Home /
CRDL2 Antibody (C-term) Blocking Peptide

CRDL2 Antibody (C-term) Blocking Peptide

Item no.	ABC-BP4764b
Manufacturer	Abcepta
Amount	500 ug
Category	Peptides & Proteins Peptides
Type	Peptides
Format	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Similar products	CHRDL2, BNF1, CHL2, Breast tumor novel factor 1, Chordin-like protein 2, Chordin-related protein 2, BNF-1
Available
Primary Accession	Q6WN34
Bio Background	CRDL2 may inhibits BMPs activity by blocking their interaction with their receptors. CRDL2 has a negative regulator effect on the cartilage formation/regeneration from immature mesenchymal cells, by preventing or reducing the rate of matrix accumulation (By similarity). CRDL2 implicated in tumor angiogenesis. CRDL2 may play a role during myoblast and osteoblast differentiation, and maturation.
Bio References	Yerges, L.M., et al. J. Bone Miner. Res. 24(12):2039-2049(2009)Zhang, Z., et al. Protein Sci. 13(10):2819-2824(2004)Oren, A., et al. Gene 331, 17-31 (2004)
Gene ID	25884
Gene Name	CHRDL2
Subtitle	Synthetic peptide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP4764b-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 10/4/2024

Express Delivery: Save 25 days

Compare

Add to wishlist

Recommend by mail